Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial-Reference-Cited by-同舟云学术

Assessment of aberrant DNA methylation two years after paediatric critical illness: a pre-planned secondary analysis of the international PEPaNIC trial

Published:2022-11-16 Issue:1 Volume:18 Page:
ISSN:1559-2294
Container-title:Epigenetics
language:en
Short-container-title:Epigenetics

Author:

Coppens Grégoire¹^ORCID,Vanhorebeek Ilse¹^ORCID,Verlinden Ines¹^ORCID,Derese Inge¹,Wouters Pieter J¹,Joosten Koen F.²^ORCID,Verbruggen Sascha C.²^ORCID,Güiza Fabian¹^ORCID,Van den Berghe Greet¹^ORCID

Affiliation:

1. Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven,Leuven, Belgium

2. Intensive Care Unit, Department of Paediatrics and Paediatric Surgery, Erasmus Medical Centre, Sophia Children’s Hospital, Rotterdam, The Netherlands

Funder

European Research Council Advanced Grants under Grant

Greet Van den Berghe; and the Methusalem program of the Flemish government

the Institute for Science and Technology, Flanders, Belgium

Research Foundation

Erasmus Trustfond

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15592294.2022.2146966